Kyongbo Pharmaceutical Co., Ltd reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported negative sales was KRW 0.00016 million compared to KRW 0.00046 million a year ago. Net loss was KRW 739.87 million compared to net income of KRW 159.63 million a year ago.

Basic loss per share from continuing operations was KRW 31 compared to basic earnings per share from continuing operations of KRW 7 a year ago. Basic loss per share was KRW 31 compared to basic earnings per share of KRW 7 a year ago.